Axonics generates another $17m
Startup Axonics Modulation Technologies brings in close to $17.3 million in equity funding for its next-generation neuromodulation technology to treat overactive bladder and other conditions.
Axonics Modulation Technologies said it raised nearly $17.3 million in an equity financing as it develops next-generation neuromodulation technology to treat various medical conditions.
The California company disclosed the funding in a recent regulatory filing that does not name specific investors.
Axonics Modulation Technologies, Vessix Vascular Inc.News Well, Funding Roundup, Neuromodulation/Neurostimulationread more
Source: Mass Device - Category: Medical Equipment Authors: Mark Hollmer Source Type: news